法律意见书 致：黑龙江天有为电子股份有限公司 根据《中华人民共和国公司法》《中华人民共和国证券法》等相关法律、法 规和规范性文件及《黑龙江天有为电子股份有限公司章程》（以下简称"公司章 程"）的规定，北京市中伦律师事务所（以下简称"本所"）接受黑龙江天有为 电子股份有限公司（以下简称"公司"）委托，指派本所律师列席了公司 2025 年 第二次临时股东大会（以下简称"本次股东大会"），对本次股东大会的相关事 项进行了见证，并在此基础上出具本法律意见书。 为出具本法律意见书，本所律师审查了公司提供的相关文件，该等文件包括 但不限于： 北京市中伦律师事务所 关于黑龙江天有为电子股份有限公司 2025 年第二次临时股东大会的 1. 现行有效的公司章程； 2. 公司于 2025 年 9 月 20 日刊登在上海证券交易所网站的公司董事会关于 召开本次股东大会的通知； 3. 公司本次股东大会股权登记日的股东名册、出席现场会议股东的到会登 记记录及凭证资料； 4. 公司本次股东大会的相关会议文件。 - 1 - 法律意见书 本法律意见书仅供公司本次股东大会之目的使用，本所律师同意将本法律意 见书随同公司本次股东大会决议及其他信 ...

证券代码：603202 证券简称：天有为 公告编号：2025-037 黑龙江天有为电子股份有限公司 2025年第二次临时股东大会决议公告 | 1、出席会议的股东和代理人人数 | 371 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 110,819,322 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 69.2621 | (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东大会由公司董事会召集。公司董事长王文博先生主持。会议采用现 场投票和网络投票相结合的表决方式。本次会议的召集、召开和表决方式符合《公 司法》和《公司章程》的有关规定。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东大会召开的时间：2025 年 10 月 20 日 (二)股东大会召开的地点：黑龙江省绥化市经济技术开发区昆山路 9 号 D26 会议 室 (三)出席 ...

Core Viewpoint - Tianyouwei experienced a decline of 1.69% on October 17, with a trading volume of 92.39 million yuan, indicating a negative market sentiment towards the company [1]. Financing Summary - On October 17, Tianyouwei had a financing buy-in amount of 5.22 million yuan and a financing repayment of 20.04 million yuan, resulting in a net financing outflow of 14.82 million yuan [1]. - As of October 17, the total financing and securities lending balance for Tianyouwei was 224 million yuan, which represents 7.33% of its circulating market value [1]. Company Overview - Tianyouwei, established on May 21, 2003, is located in the Suifenhe Economic and Technological Development Zone, Heilongjiang Province, and specializes in the research, design, production, sales, and service of automotive instruments, with a gradual expansion into the smart cockpit sector [1]. - As of September 30, the number of shareholders for Tianyouwei was 25,400, a decrease of 0.56% from the previous period, while the average circulating shares per person increased by 0.57% to 1,278 shares [1]. Financial Performance - For the period from January to June 2025, Tianyouwei reported a revenue of 2.03 billion yuan, a year-on-year decrease of 0.49%, and a net profit attributable to shareholders of 526 million yuan, down 4.50% year-on-year [1]. Dividend Information - Since its A-share listing, Tianyouwei has distributed a total of 558 million yuan in dividends [2]. Institutional Holdings - As of June 30, 2025, the third-largest circulating shareholder of Tianyouwei was the Jiangyin Alpha Core Mixed A fund, which holds 178,300 shares as a new shareholder [2].

Group 1 - The report highlights that the performance forecasts for Q3 2025 in the electronics and basic chemicals sectors are promising, with over 10 companies expected to achieve a profit growth rate exceeding 30% year-on-year [3][29] - In the electronics sector, the AI wave is driving high growth, with AI inference creating new demand, suggesting that the sector is likely to maintain a high prosperity level [3][29] - The basic chemicals sector is experiencing structural improvement due to supply constraints and demand support, with an overall balance of supply and demand expected to improve as capacity adjustments take place [3][29] Group 2 - The report indicates that as of October 15, 2025, 154 companies in the A-share market have disclosed their Q3 2025 performance forecasts or reports, with a disclosure rate of approximately 2.83% and a pre-positive forecast rate of about 83.06% [3][30] - The median net profit growth rate for the sample companies disclosing their performance forecasts is 71.2% under the median method and 65.6% under the overall method [3][30] - The report identifies that the sectors with the highest pre-positive forecast rates include comprehensive, non-bank financial, and social services, all at 100% [3][30] Group 3 - The medical device sector saw a decline in revenue and net profit in H1 2025, with overall revenue down 7.3% and net profit down 27.0% year-on-year [8] - However, the bidding process is recovering, with the total amount of domestic medical device bids in H1 2025 reaching 83.8 billion yuan, a year-on-year increase of 64% [8] - Companies like United Imaging and Mindray are experiencing growth in overseas revenues, indicating a trend towards globalization in the medical device market [8] Group 4 - The report emphasizes the importance of AI hardware and domestic computing power as key investment areas, suggesting that the market may continue to see structural slow growth with technology remaining a core focus [10] - The electronics sector is expected to see significant advancements in AI terminal ecosystems, with hardware innovation and computing power working in synergy, potentially leading to a boom in 2026 [12] - The report also notes that major companies like Apple are enhancing their collaboration in the AI space, which could lead to a reevaluation of industry valuations [12]

Group 1: Cash Management of Idle Funds - The company has approved the use of up to RMB 28 billion of idle raised funds and up to RMB 20 billion of idle self-owned funds for cash management, focusing on safe and liquid principal-protected financial products [1] - As of the announcement date, the company has redeemed idle funds amounting to RMB 30 million, generating a profit of RMB 1.0231 million, with all principal and interest returned to the fundraising account [2] - The total amount of idle raised funds under cash management that has not yet matured is RMB 850 million, with no overdue amounts reported [2] Group 2: Restricted Stock Listing - The company will list 718,386 shares of restricted stock on October 24, 2025, following the expiration of a six-month lock-up period since its initial public offering [4][7] - The restricted shares represent 0.45% of the company's total shares, which were part of the offline issuance under a proportionate lock-up method [5][6] - The company has confirmed that all shareholders of the restricted stock have complied with their commitments, and the listing complies with relevant regulations [6]

Core Points - The company Tianyouwei (603202) announced the listing of its shares as a first-time public offering [1] - The total number of shares available for subscription is 718,386 shares [1] - The shares will be available for trading starting from October 24, 2025 [1] Summary by Category - **Company Announcement** - Tianyouwei has released an announcement regarding its stock listing [1] - The listing type is categorized as a first-time public offering [1] - **Stock Details** - The total number of shares listed for circulation is 718,386 [1] - The method of subscription for the shares is through offline channels [1] - **Trading Information** - The shares will commence trading on October 24, 2025 [1]

黑龙江天有为电子股份有限公司 首次公开发行限售股上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次股票上市类型为首发股份；股票认购方式为网下，上市股数为718,386 股。 证券代码： 603202 证券简称： 天有为 公告编号： 2025-034 四、中介机构核查意见 本次股票上市流通总数为718,386股。 本次股票上市流通日期为2025 年 10 月 24 日。 一、本次限售股上市类型 根据中国证券监督管理委员会《关于同意黑龙江天有为电子股份有限公司首 次公开发行股票注册的批复》（证监许可〔2024〕1900 号），并经上海证券交易所 同意，黑龙江天有为电子股份有限公司（以下简称"公司"）首次向社会公开发行人 民币普通股（A 股）40,000,000 股，并于 2025 年 4 月 24 日在上海证券交易所主板 上市，发行完成后总股本为 160,000,000 股，其中有限售条件流通股 127,456,348 股，无限售条件流通股 32,543,652 股。 本次解除限售并上市流通的限 ...

中信建投证券股份有限公司 关于黑龙江天有为电子股份有限公司 三、本次限售股上市流通的有关承诺 本次上市流通的限售股属于公司首次公开发行网下配售限售股。根据公司 《首次公开发行股票并在主板上市招股说明书》及《首次公开发行股票主板上市 公告书》，网下发行部分采用比例限售方式，网下投资者承诺其获配股票数量的 10%（向上取整计算）限售期限为自发行人首次公开发行并上市之日起 6 个月。 即每个配售对象获配的股票中，90%的股份无限售期，自本次发行股票在上交所 上市交易之日起即可流通；10%的股份限售期为 6 个月，限售期自本次发行股票 在上交所上市交易之日起开始计算。 除上述承诺外，本次申请上市流通的限售股股东无其他特别承诺。截至本公 告披露日，本次申请上市的限售股股东均严格履行相应的承诺事项，不存在相关 承诺未履行影响本次限售股上市流通的情况。 四、本次限售股上市流通情况 1、本次上市流通的限售股总数为 718,386 股，限售期为自公司首次公开发 行股票上市之日起 6 个月。 首次公开发行限售股上市流通的核查意见 一、本次限售股上市类型 根据中国证券监督管理委员会《关于同意黑龙江天有为电子股份有限公司首 次公开发 ...

| 产 | 产 | 受 | 实际年化 | 品 | 品 | 认购 | 实际 | 实际赎回 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 托 | 到期日 | 收益率 | 实际收益 | 类 | 名 | 金额 | 起息日 | 本金 | 方 | （%） | | 型 | 称 | 银 | 单 | | | | | | | | | 农 | 行 | 位 | 业 | 定 | 定 | | | | | | | 10,000 | 2025/10/16 | 10,000 | 0.9 | 2025/7/16 | 22.50 | 银 | 期 | 期 | | | | 行 | 存 | 存 | 款 | 款 | | | | | | | | 质 | 押 | | | | | | | | | | | 中 | 天 | 式 | 信 | 天 | | | | | | | | 报 | 20,000 | 20,000 | 1.6 | 79.81 | 2025/7/17 | 2025/10/16 | 证 | 利 | 价 | | | 券 | 财 | 回 | | | | ...

Summary of Key Points Core Viewpoint - The article discusses the issuance of new stocks in China, highlighting the total amount raised and the distribution of funds across various sectors and regions in 2023 [1][2]. Group 1: New Stock Issuance - A new stock, Bibet, was issued today with 90 million shares at a price of 17.78 yuan, raising 1.6 billion yuan [1]. - As of October 17, 2023, a total of 82 companies have gone public this year, raising a cumulative amount of 87.517 billion yuan, with an average fundraising of 1.067 billion yuan per company [1][2]. - Among these, 18 companies raised over 1 billion yuan, and 1 company raised over 10 billion yuan [1]. Group 2: Fundraising by Market Segment - In the Shanghai Stock Exchange, 18 new stocks were issued, raising 38.157 billion yuan; in the Shenzhen Stock Exchange, 10 stocks raised 7.925 billion yuan; the ChiNext board had 27 stocks raising 19.316 billion yuan; the Sci-Tech Innovation Board had 10 stocks raising 16.736 billion yuan; and the Beijing Stock Exchange had 17 stocks raising 5.383 billion yuan [1]. - Huadian New Energy is the top fundraiser this year, raising 18.171 billion yuan primarily for wind and solar power projects [1][2]. Group 3: Pricing and Regional Distribution - The average initial public offering (IPO) price this year is 21.04 yuan, with 4 companies pricing above 50 yuan; the highest price is 93.50 yuan for Tianyouwei [2]. - The majority of new stock issuances are concentrated in Jiangsu, Guangdong, and Zhejiang, with 20, 16, and 13 companies respectively; the top fundraising regions are Fujian, Guangdong, and Jiangsu, raising 18.171 billion yuan, 13.916 billion yuan, and 12.688 billion yuan respectively [2].